Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
Hive Digital Technologies stock surged this week thanks to a major AI infrastructure project from its subsidiary. Thi...
Two top gene-editing names, two very different strategies. This guide breaks down CRISPR Therapeutics and Editas Medi...
Ripple unveils a day-one Open USD partnership as XRP hovers near $1, with RLUSD clearing regulatory hurdles and insti...
Cloudflare surged about 9% in midday trading after a Scotiabank upgrade. The move comes as AI cloud peers like Oracle...
NVIDIA is at the center of the AI hardware boom, fueling bets that the stock will climb to new highs by 2027. Analyst...
CoStar Group appoints Robin Rossmann as chief financial officer, effective July 31, 2026, succeeding Christian Lown. ...
The iShares MSCI Japan ETF is at the center of a major market overhaul in Japan, delivering broad exposure to a shift...
A dominant market infrastructure firm sits at the heart of capital markets, wielding a legally protected financial mo...
Conagra (CAG) faces a pivotal year as 2026 earnings hinge on pricing, cost control, and portfolio focus. This analysi...
Fannie Mae and Freddie Mac unveiled a wave of condo lending changes, aimed at stabilizing costs and risk. The new rul...
Quantum computing stocks moved lower in Monday trading as investors rotated into safer assets amid a broader tech mar...